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Editorial on the Research Topic
Hypoxia in Kidney Disease
INTRODUCTION
Oxygen was first described by Carl Wilhelm Scheele as “Fire air” since it supported combustion.
He obtained oxygen by heating mercuric oxide, silver carbonate, and nitrate salts. Scheele
communicated his findings to Lavoisier, who realized the significance of this finding. Scheele’s
discovery of oxygen (ca. 1771) was chronologically earlier than the corresponding work of Priestley
and Lavoisier, but he did not publish this discovery until 1777, after both of his rivals had already
published their findings (West, 2014). Because others generally are accredited for the discovery of
oxygen, and a number of other discoveries, he was nicknamed “hard-luck Scheele.”
Oxygen is essential for aerobic metabolism, a fundamental mechanism for energy production.
The delivery of optimal levels of oxygen to tissues is tightly regulated as both hypoxia and hyperoxia
are detrimental for cellular function. Indeed, tissue hypoxia has been found during pathological
conditions such as cancer (Liu et al., 2016), diabetes (Palm et al., 2003), hypertension (Welch et al.,
2001), chronic kidney disease (CKD) (Milani et al., 2016), and stroke (Ferdinand and Roffe, 2016).
In the 90’s Fine et al. proposed kidney hypoxia as a mediator of progressive kidney disease (Fine
et al., 1998). Since then, experimental and clinical studies have solidified the view that kidney
hypoxia plays a critical role during the genesis and progression of both acute and CKD. This
research field is currently at the beginning of integrating pre-clinical with clinical research in which
kidney hypoxia related mechanisms are quantified by non-invasive imaging. In combination with
the fact that some key questions remain unanswered, this offers exciting new research perspectives
that are waiting to be explored.With this Frontiers Research Topic we discuss and identify potential
mediators/controllers of hypoxia in kidney disease. If we understand more about the sequence of
events leading to kidney hypoxia, its regulation and consequences in renal disease, we might be able
to have a major impact in clinical practice. I.e., more accurate and earlier diagnosis, novel treatment
targets, and novel therapies.
HYPOXIA IN KIDNEY DISEASE
Liu et al. describes the alterations in renal oxygenation (delivery, consumption and tissue oxygen
tension) in pre-clinical and clinical studies in diabetic and hypertensive CKD along with the
underlying mechanisms and potential therapeutic options. The novel hypothesis by Patinha et al.
on the cooperative oxygen sensing by the kidney and carotid body in blood pressure control, could
further explain the role of kidney hypoxia in hypertension. This is relevant for the pursuit of novel
ways to treat associated with sympathetic overdrive. Indeed, Hering et al. reduced sympathetic
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nerve activity and lowered blood pressure in CKD patients using
100% oxygen (Hering et al., 2007). Furthermore, van der Bel
et al. assessed the underlying hemodynamic modulation and
found that oxygen supplementation in CKD patients caused
a non-baroreflex-mediated increase in vascular resistance and
blood pressure. Conceivably, within their experimental set-up,
the effects of oxygen on systemic vasoconstriction (leading to
baroreflex deactivation with reduction in sympathetic tone) did
not allow for the detection of any possible subtle effects of kidney
specific oxygenation on sympathetic outflow.
Maekawa et al. describes that elevated levels of the uremic
toxin indoxyl sulfate (IS) in CKD can induce endoplasmatic
reticulum (ER) stress and subsequent hypoxia through
suppression of erythropoiesis and exacerbation of tubular
fibrosis. They propose that the removal of IS, blockage
of aryl hydrocarbon receptor (mediator of IS-induced
suppression of erythropoietin production), inhibition of
hepcidin production (controls iron homeostasis) and mediation
of the ER unfolded protein pathway could be therapeutic targets
in ameliorating hypoxia and subsequent CKD progression.
Preserving mitochondrial uncoupling might be a potential
treatment target. Indeed, kidney hypoxia per se, caused by
mitochondrial uncoupling, without confounding factors
such as uraemia, hyperglycaemia or hypertension results
in albuminuria and tubulointerstitial damage (Friederich-
Persson et al., 2013). Schiffer et al. proposes that diabetic
nephropathy is likely a joint mechanism of mitochondrial
reactive oxygen species production, which include altered
mitophagy, mitochondrial dynamics, mitochondrial uncoupling,
and signaling through AMP-activated protein kinase and
hypoxia-inducible factors. Therefore, prevention or correction of
mitochondrial dysfunction might be pivotal in treating diabetic
kidney disease.
HYPOXIA QUANTIFICATION IN KIDNEY
DISEASE
Hirakawa et al. addresses the pathophysiological importance
of renal hypoxia with a focus on hypoxia detection and
quantification. Although kidney tissue oxygenation has been
studied for a long time, recent advances have made it
possible to achieve continuous measurements, non-invasive
oxygen assessments, and intracellular oxygen assessments. Using
oxygen tension telemetry Emans et al. demonstrate circadian
variation in kidney tissue oxygenation with maximal values
during the lights-off period, when renal excretion of electrolytes
was highest. These type of experiments will allow long-term
investigation of kidney oxygenation in relation to disease
development, including the investigation of circadian influence
on normal physiology and disease development (Adamovich
et al., 2017). Blood Oxygenation-Level Dependent (BOLD)
magnetic resonance imaging (MRI) allows for non-invasive
estimation of kidney oxygenation in humans, without the
need for administration of exogenous contrast agents. Pruijm
et al. summarizes the growing knowledge of factors that
influence the BOLD-signal and how this has led to better
standardization, refinements, and reproducibility. BOLD, alone
or in combination with other MRI modalities, could therefore
contribute to patient stratification, earlier diagnosis, and improve
long-term follow up. Indeed, Eijs et al. report that functional
MRI (including BOLD) has the potential to detect several
pathophysiological mechanisms involved in kidney allograft
dysfunction, making it a promising tool in long-term follow-
up of kidney transplantation patients. In addition, Cox et al.
showed in a pilot study that multiparametric MRI could assess
renal structure, hemodynamics and oxygenation in healthy
participants and CKD patients. Renal blood flow and renal
cortex perfusion was lower in CKD patients compared with
healthy participants. Longitudinal relaxation time (T1 values), an
MRI parameter that increases with reduced perfusion/filtration
and/or progressive scarring, were increased in both renal
cortex and medulla compared to healthy participants, though
primarily in cortex, resulting in a loss of corticomedullary
differentiation. Finally, Laustsen describes how the introduction
of dissolution dynamic nuclear polarization technology has
enabled a new paradigm for renal MRI. They describe the utility
of hyperpolarized MRI in preclinical research in which the real-
time interrogation of metabolic turnover has already aided the
physiological and pathophysiological metabolic and functional
effects in ex vivo and in vivo models, and discus its potential
translation to renal patients.
CONCLUSION
This research topic highlights the important role of hypoxia in
kidney disease and what progress has been made to address
its importance. We conclude that it is imperative to further
advance our understanding about the sequence of events leading
to intrarenal tissue hypoxia, its regulation and consequences in
both acute and CKD. If we do that, we might be able to end
Scheele’s “hard-luck” and have a major impact of patient care
and reduce the poor quality of life often associated with kidney
disease.
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